Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients must have a diagnosis of Rheumatoid Arthritis at least 3 months before screening~* If the patient is of childbearing potential, must have been using adequate birth control measures~* Patients must be receiving MTX for =3 months before randomization and at a stable dose(=25 mg/week) for =4 weeks before randomization~Exclusion Criteria:~* Patients must not be pregnant, nursing, or planning a pregnancy within 18 months of enrollment~* Patients must not have rheumatic disease other than Rheumatoid Arthritis or had any systemic inflammatory condition~* Patients must not be confined to a wheelchair~* Patients must not be treated with any approved or investigational biologic agent except for approved vaccines for immunizations

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).